News. 03/07/12

Procuritas announces the final closing of Procuritas Capital Investors V (PCI V), at EUR 200 million

Press Release, Guernsey

Procuritas Capital Investors V GP Ltd. (PCI V GP) announced the closing of the fifth Procuritas fund – PCI V – at EUR 200 million. The fund is advised by Procuritas AB and Procuritas Partners GmbH. PCI V is backed by a list of existing and new blue chip investors.

PCI V will continue to invest using the same strategy and methodology as the previous Procuritas’ advised funds, i.e., focusing on mid-market investment opportunities in the Nordic market. Active ownership will be applied together with a dedication to growth and operational improvements, with the aim to develop the businesses into leading companies within their respective markets.

About Procuritas

Procuritas is a Nordic private equity house specialized in initiating, structuring and financing buy-outs. Founded in 1986, the company was the pioneer in introducing the concept of management buy-outs in the Nordic region. Procuritas advised funds have made 32 investments to date and fully realized 22.

More news.

09/04/24

Polarn O. Pyret appoints Sara Sjöberg as new CEO

Procuritas Capital Investors VI (”Procuritas”), the Swedish private equity firm dedicated to growing Nordic mid-market enterprises, is delighted to announce the appointment of Sara Sjöberg as the forthcoming Chief Executive Officer for its portfolio company, Polarn O. Pyret, the iconic Swedish childrenswear brand. Sara Sjöberg steps into this role with a wealth of experience from...

 08/04/24

Humana to acquire Team Olivia’s Norwegian operation

Team Olivia, a leading care service provider in the Nordics has entered into an agreement to sell its Norwegian operations, Team Olivia Norge AS, to Human Care Holding AS (“Humana”). The Transaction is subject to approval by the Norwegian competition authority and is expected to be completed during the second quarter of 2024. Team Olivia,...

 28/02/24

Procuritas partners up with Precision BioLogic

Procuritas Capital Investors VII (Procuritas) acquires Precision BioLogic (PBI) and subsidiary (Affinity Biologicals), fast-growing niche leaders in hemostasis diagnostics and research. PBI has in recent years launched a number of successful diagnostics products and is active in a growing market, supported by long-term trends such as ageing population, emerging new therapies, and increased access to...